🇺🇸 FDA
Pipeline program

CYTARABINE , LONCASTUXIMAB TESIRINE, RITUXIMAB, BENDAMUSTINE

FIL_COLUMN

Phase 2 small_molecule active

Quick answer

CYTARABINE , LONCASTUXIMAB TESIRINE, RITUXIMAB, BENDAMUSTINE for Mantle cell lymphoma is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
Mantle cell lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials